data_2hm6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hm6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.609 0.242 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HB2' HG21 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.513 -0.442 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.526 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.538 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.55 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.521 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 CA--C 1.512 -0.514 0 CA-C-O 120.41 0.147 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.594 0.235 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HB2' HG21 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -85.14 153.45 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.325 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 151.67 21.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 4' ' ' ILE . 29.5 mm -104.88 134.92 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.9 p -63.86 -50.26 69.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.47 -71.81 0.05 OUTLIER Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.283 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -171.51 -63.08 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.55 134.44 72.86 Favored Pre-proline 0 CA--C 1.516 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.528 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.99 84.93 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -86.25 -53.18 5.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.159 0.979 . . . . 0.0 111.397 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -85.71 152.61 22.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.224 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.24 -63.9 2.81 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.754 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -72.01 80.64 0.93 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.36 124.44 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -103.07 169.01 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.6 tp 61.23 67.55 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.766 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.03 161.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.63 143.35 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.93 131.59 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -147.65 -20.97 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.524 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.92 88.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.416 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 m -84.23 -46.17 12.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m -74.83 130.06 82.04 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.79 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HB2' HG21 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.894 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.41 10.09 82.56 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.613 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.3 m -85.6 -35.34 21.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.905 0.852 . . . . 0.0 109.62 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -154.25 151.35 29.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.279 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.63 -72.27 0.4 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.733 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.78 98.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.633 0.254 . . . . 0.0 111.05 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.894 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 27.0 m -64.13 144.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.958 0.409 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -121.7 163.63 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.036 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.37 59.76 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.18 0.514 . . . . 0.0 110.707 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.793 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 136.2 54.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.67 0.271 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.41 140.5 49.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -121.98 132.16 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.7 m -111.01 -19.19 12.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.89 60.01 6.91 Favored Glycine 0 CA--C 1.508 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.581 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -177.51 -57.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.03 0.443 . . . . 0.0 110.174 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.45 123.74 88.71 Favored Pre-proline 0 CA--C 1.513 -0.442 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.246 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.64 82.57 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.5 m -85.82 -35.97 20.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.77 0.785 . . . . 0.0 109.467 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.32 151.36 28.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.669 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.91 -81.09 1.11 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.369 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -50.17 98.73 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.838 0.352 . . . . 0.0 110.907 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.674 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 33.0 m -80.56 140.2 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.479 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -90.96 71.19 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.44 46.92 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p 49.7 88.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.89 0.376 . . . . 0.0 111.348 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.94 78.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -100.21 134.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -54.85 -46.45 74.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.124 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.83 -59.06 0.5 Allowed Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.582 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 m -83.52 -44.99 14.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.91 0.385 . . . . 0.0 110.527 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m -74.5 130.8 81.19 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.512 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.526 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.86 9.35 86.41 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.632 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.9 m -85.84 -33.28 21.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.95 0.875 . . . . 0.0 110.379 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 p -153.83 151.37 29.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.325 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.61 85.0 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -126.49 82.06 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 28' ' ' VAL . 35.2 m -92.75 131.66 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.204 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -156.8 157.87 35.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -161.46 60.71 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p 54.45 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.01 103.84 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.672 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 4' ' ' ILE . 19.1 mm -120.6 133.8 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -103.01 -29.05 11.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.789 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.51 80.4 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.464 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -85.14 -48.71 8.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.74 131.87 78.8 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.538 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.88 15.3 81.75 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.2 m -85.5 -33.67 21.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.501 0.65 . . . . 0.0 109.846 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.128 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.96 81.25 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 89.09 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 28' ' ' VAL . 35.9 m -86.03 116.37 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.048 0.452 . . . . 0.0 111.115 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.77 142.26 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.106 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.87 24.89 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.285 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.926 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.73 139.64 53.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.61 88.05 2.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.976 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.3 mm -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.196 0.522 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -138.55 -24.78 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.293 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.05 77.12 1.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.166 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -85.59 -50.93 6.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.36 135.01 72.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.516 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.76 80.69 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -85.95 -52.82 5.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.544 0.672 . . . . 0.0 110.828 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.9 152.75 22.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.036 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.85 -56.08 9.97 Favored Glycine 0 C--N 1.319 -0.364 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.936 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 3.2 pm0 -57.35 100.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . 29.3 m -85.14 115.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.38 132.36 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.794 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.87 39.71 3.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -142.73 158.57 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.717 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -133.88 122.8 23.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.73 153.42 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 5' ' ' THR . 33.4 m -115.95 -18.25 10.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.561 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.84 49.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 m -81.94 -47.47 12.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.982 0.42 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 m -74.83 131.76 78.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.418 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.55 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.06 10.14 83.21 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.611 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -85.76 -34.75 21.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.98 0.89 . . . . 0.0 110.337 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.187 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.68 81.2 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.97 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -106.25 81.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.117 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.46 127.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.98 87.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.89 50.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.61 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 95.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.16 127.3 56.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -155.96 151.31 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 110.933 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -64.29 131.87 48.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.08 1.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -85.42 -52.14 6.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.901 0.381 . . . . 0.0 110.691 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.26 133.21 75.12 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.311 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.521 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.13 80.78 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 m -85.85 -51.98 6.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.56 0.68 . . . . 0.0 110.801 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.73 152.78 22.79 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.057 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.53 83.54 0.18 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.219 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.47 94.61 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.08 134.09 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -139.21 114.68 9.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.88 27.33 7.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.88 0.372 . . . . 0.0 110.834 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.838 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -66.05 85.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -103.6 128.38 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.684 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -49.59 146.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.4 m -110.54 -25.37 10.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.937 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.25 90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.458 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -86.13 -58.47 2.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.0 110.242 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.55 124.43 88.91 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.785 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.609 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.54 8.18 86.5 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.4 m -85.83 -34.21 21.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.013 0.906 . . . . 0.0 109.946 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -153.99 151.4 29.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.377 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.22 98.29 0.11 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.327 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -98.92 84.87 3.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.49 137.3 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 62.0 85.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.76 28.21 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.344 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.944 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t 60.77 156.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.77 143.21 39.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.699 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -154.3 147.33 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.76 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -125.42 -28.41 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 0.0 111.386 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.45 -82.57 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -161.86 -69.43 0.06 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m -75.16 124.61 89.41 Favored Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.26 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HB2' HG21 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.6 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 8.61 86.49 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.6 m -85.94 -35.74 20.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.089 0.944 . . . . 0.0 110.489 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -153.93 151.37 29.35 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.049 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.41 95.36 0.1 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.816 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -129.14 61.03 1.54 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 110.868 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.59 117.26 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 54.74 87.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -107.61 50.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.624 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.831 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.51 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.609 0.242 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.513 -0.442 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 9' ' ' PRO . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.549 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' PRO . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 CA--C 1.512 -0.514 0 CA-C-O 120.41 0.147 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.594 0.235 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB2' HG22 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 9' ' ' PRO . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.536 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -85.14 153.45 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.325 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 151.67 21.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mm -104.88 134.92 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.9 p -63.86 -50.26 69.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.47 -71.81 0.05 OUTLIER Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.283 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -171.51 -63.08 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.55 134.44 72.86 Favored Pre-proline 0 CA--C 1.516 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.528 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.51 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.99 84.93 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -86.25 -53.18 5.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.159 0.979 . . . . 0.0 111.397 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -85.71 152.61 22.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.224 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.24 -63.9 2.81 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.754 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -72.01 80.64 0.93 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.36 124.44 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -103.07 169.01 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.6 tp 61.23 67.55 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.766 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.03 161.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.63 143.35 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.93 131.59 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -147.65 -20.97 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.524 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.92 88.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.416 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 m -84.23 -46.17 12.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m -74.83 130.06 82.04 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.79 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.924 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.41 10.09 82.56 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.3 m -85.6 -35.34 21.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.905 0.852 . . . . 0.0 109.62 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -154.25 151.35 29.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.279 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.63 -72.27 0.4 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.733 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.78 98.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.633 0.254 . . . . 0.0 111.05 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.924 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 27.0 m -64.13 144.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.958 0.409 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -121.7 163.63 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.036 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.37 59.76 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.18 0.514 . . . . 0.0 110.707 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.793 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 136.2 54.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.67 0.271 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.41 140.5 49.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -121.98 132.16 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.7 m -111.01 -19.19 12.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.89 60.01 6.91 Favored Glycine 0 CA--C 1.508 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.581 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -177.51 -57.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.03 0.443 . . . . 0.0 110.174 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.45 123.74 88.71 Favored Pre-proline 0 CA--C 1.513 -0.442 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.246 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.695 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.64 82.57 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.5 m -85.82 -35.97 20.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.77 0.785 . . . . 0.0 109.467 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.32 151.36 28.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.669 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.91 -81.09 1.11 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.369 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -50.17 98.73 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.838 0.352 . . . . 0.0 110.907 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 33.0 m -80.56 140.2 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.479 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -90.96 71.19 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.44 46.92 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p 49.7 88.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.89 0.376 . . . . 0.0 111.348 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.94 78.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -100.21 134.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -54.85 -46.45 74.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.124 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.83 -59.06 0.5 Allowed Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.582 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 m -83.52 -44.99 14.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.91 0.385 . . . . 0.0 110.527 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m -74.5 130.8 81.19 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.512 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.86 9.35 86.41 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.646 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.9 m -85.84 -33.28 21.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.95 0.875 . . . . 0.0 110.379 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 p -153.83 151.37 29.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.325 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.61 85.0 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -126.49 82.06 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -92.75 131.66 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.204 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -156.8 157.87 35.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -161.46 60.71 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p 54.45 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.01 103.84 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.672 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 mm -120.6 133.8 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -103.01 -29.05 11.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.789 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.51 80.4 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.464 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -85.14 -48.71 8.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.74 131.87 78.8 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 9' ' ' PRO . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.88 15.3 81.75 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.2 m -85.5 -33.67 21.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.501 0.65 . . . . 0.0 109.846 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.128 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.96 81.25 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 89.09 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' VAL . 35.9 m -86.03 116.37 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.048 0.452 . . . . 0.0 111.115 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.77 142.26 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.106 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.87 24.89 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.285 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.926 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.73 139.64 53.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.61 88.05 2.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.976 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.3 mm -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.196 0.522 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -138.55 -24.78 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.293 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.05 77.12 1.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.166 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -85.59 -50.93 6.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.36 135.01 72.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.76 80.69 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -85.95 -52.82 5.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.544 0.672 . . . . 0.0 110.828 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.9 152.75 22.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.036 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.85 -56.08 9.97 Favored Glycine 0 C--N 1.319 -0.364 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.936 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 3.2 pm0 -57.35 100.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 28' ' ' VAL . 29.3 m -85.14 115.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.38 132.36 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.794 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.87 39.71 3.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -142.73 158.57 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.717 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -133.88 122.8 23.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 HD12 ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -154.73 153.42 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.332 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -115.95 -18.25 10.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.561 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.84 49.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 m -81.94 -47.47 12.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.982 0.42 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 4' ' ' ILE . 27.6 m -74.83 131.76 78.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.418 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.549 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.06 10.14 83.21 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -85.76 -34.75 21.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.98 0.89 . . . . 0.0 110.337 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.187 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.68 81.2 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.97 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -106.25 81.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.117 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.46 127.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.98 87.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.89 50.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.61 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 95.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.16 127.3 56.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -155.96 151.31 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 110.933 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -64.29 131.87 48.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.08 1.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -85.42 -52.14 6.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.901 0.381 . . . . 0.0 110.691 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.26 133.21 75.12 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.311 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' PRO . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.13 80.78 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 m -85.85 -51.98 6.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.56 0.68 . . . . 0.0 110.801 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.73 152.78 22.79 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.057 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.53 83.54 0.18 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.219 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.47 94.61 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.08 134.09 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -139.21 114.68 9.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.88 27.33 7.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.88 0.372 . . . . 0.0 110.834 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.838 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -66.05 85.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -103.6 128.38 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.684 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -49.59 146.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.4 m -110.54 -25.37 10.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.937 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.25 90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.458 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -86.13 -58.47 2.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.0 110.242 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.55 124.43 88.91 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.785 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.54 8.18 86.5 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.4 m -85.83 -34.21 21.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.013 0.906 . . . . 0.0 109.946 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -153.99 151.4 29.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.377 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.22 98.29 0.11 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.327 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -98.92 84.87 3.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.49 137.3 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 62.0 85.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 2.3 pp -94.76 28.21 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.344 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 m120 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.944 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t 60.77 156.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.77 143.21 39.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.699 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.8 pp -154.3 147.33 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.76 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -125.42 -28.41 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 0.0 111.386 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.45 -82.57 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -161.86 -69.43 0.06 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m -75.16 124.61 89.41 Favored Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.26 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB2' HG22 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 9' ' ' PRO . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.536 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 8.61 86.49 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.613 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.6 m -85.94 -35.74 20.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.089 0.944 . . . . 0.0 110.489 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -153.93 151.37 29.35 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.049 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.41 95.36 0.1 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.816 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -129.14 61.03 1.54 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 110.868 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.59 117.26 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 54.74 87.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -107.61 50.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.624 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.831 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.51 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.609 0.242 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.513 -0.442 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 9' ' ' PRO . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.549 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.515 -0.403 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' PRO . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m . . . . . 0 CA--C 1.512 -0.514 0 CA-C-O 120.41 0.147 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.594 0.235 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB2' HG22 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 9' ' ' PRO . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.536 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -85.14 153.45 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.325 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 151.67 21.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mm -104.88 134.92 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.9 p -63.86 -50.26 69.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.598 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.47 -71.81 0.05 OUTLIER Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.283 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -171.51 -63.08 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.55 134.44 72.86 Favored Pre-proline 0 CA--C 1.516 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.528 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 35.9 Cg_exo -58.9 136.14 71.53 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.031 1.154 . . . . 0.0 110.153 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -47.5 -33.13 5.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.766 0.793 . . . . 0.0 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.51 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -58.03 -27.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.46 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -71.93 -22.69 61.44 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -34.37 74.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.76 -88.93 1.84 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.112 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.23 108.14 15.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.77 59.77 4.96 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.847 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.36 160.19 82.05 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.58 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -41.49 -22.14 0.15 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.734 2.956 . . . . 0.0 114.445 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.51 -21.92 62.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.284 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 m -68.23 124.66 90.27 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 12.1 Cg_endo -68.32 168.32 19.76 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.986 1.791 . . . . 0.0 111.981 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.65 129.46 27.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.72 2.947 . . . . 0.0 114.208 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.99 84.93 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -86.25 -53.18 5.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.159 0.979 . . . . 0.0 111.397 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -85.71 152.61 22.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.224 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.24 -63.9 2.81 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.754 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -72.01 80.64 0.93 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.36 124.44 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -103.07 169.01 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.6 tp 61.23 67.55 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.766 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.03 161.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.63 143.35 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.93 131.59 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 111.119 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -147.65 -20.97 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.524 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.92 88.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.416 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 m -84.23 -46.17 12.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.031 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 m -74.83 130.06 82.04 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.79 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' A' ' 11' ' ' VAL . 37.5 Cg_exo -55.81 139.72 84.19 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.542 1.495 . . . . 0.0 110.427 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.6 m -47.5 -32.3 5.12 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.4 m -58.14 -27.81 32.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.1 m -71.68 -24.4 61.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -69.73 -35.04 74.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.54 -83.42 1.7 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.258 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.26 109.71 16.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.295 0.569 . . . . 0.0 112.328 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.924 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 32.2 t -82.36 52.55 2.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.685 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.77 159.04 85.54 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.072 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -54.34 -10.98 2.52 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.222 2.615 . . . . 0.0 114.869 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.39 64.99 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.16 124.67 89.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.747 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 11.8 Cg_endo -59.28 172.51 1.81 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.271 1.981 . . . . 0.0 112.094 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.92 125.41 16.47 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.401 2.734 . . . . 0.0 113.35 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.41 10.09 82.56 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.3 m -85.6 -35.34 21.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.905 0.852 . . . . 0.0 109.62 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -154.25 151.35 29.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.279 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.63 -72.27 0.4 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.733 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.78 98.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.633 0.254 . . . . 0.0 111.05 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.924 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 27.0 m -64.13 144.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.958 0.409 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -121.7 163.63 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.036 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.37 59.76 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.18 0.514 . . . . 0.0 110.707 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.793 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 136.2 54.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.67 0.271 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.41 140.5 49.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -121.98 132.16 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.7 m -111.01 -19.19 12.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.89 60.01 6.91 Favored Glycine 0 CA--C 1.508 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.581 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -177.51 -57.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.03 0.443 . . . . 0.0 110.174 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.45 123.74 88.71 Favored Pre-proline 0 CA--C 1.513 -0.442 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.246 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 38.7 Cg_exo -54.04 140.34 70.06 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.744 1.629 . . . . 0.0 109.994 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.2 p -47.46 -32.88 5.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.492 0.663 . . . . 0.0 111.231 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.2 m -58.32 -26.23 29.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 80.2 m -71.33 -24.43 62.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.73 -35.0 74.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.51 -82.81 1.68 Allowed Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.435 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' VAL . 7.0 m-20 -80.84 109.49 15.45 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.338 0.589 . . . . 0.0 112.264 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.695 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 48.2 t -82.6 51.26 1.83 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.263 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.16 159.38 84.67 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.285 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -54.98 -10.71 2.93 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.311 2.674 . . . . 0.0 115.003 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -70.11 -29.44 66.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.6 m -67.29 124.74 89.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.436 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.0 Cg_endo -61.48 173.83 2.48 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.097 1.864 . . . . 0.0 112.503 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.73 126.35 20.28 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.668 2.912 . . . . 0.0 113.382 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.64 82.57 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 115.335 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.5 m -85.82 -35.97 20.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.77 0.785 . . . . 0.0 109.467 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.32 151.36 28.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.669 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.91 -81.09 1.11 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.369 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -50.17 98.73 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.838 0.352 . . . . 0.0 110.907 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 33.0 m -80.56 140.2 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.479 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -90.96 71.19 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.44 46.92 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p 49.7 88.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.89 0.376 . . . . 0.0 111.348 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.94 78.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -100.21 134.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -54.85 -46.45 74.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.124 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.83 -59.06 0.5 Allowed Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.582 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 m -83.52 -44.99 14.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.91 0.385 . . . . 0.0 110.527 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 m -74.5 130.8 81.19 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.512 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.9 Cg_exo -56.94 139.44 89.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.491 1.461 . . . . 0.0 110.306 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -47.19 -33.21 5.08 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.504 0.669 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 3.0 m -58.25 -27.53 32.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -71.54 -23.12 61.71 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.213 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -35.34 75.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -82.92 1.69 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.542 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.84 110.49 16.41 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.49 0.662 . . . . 0.0 112.525 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.61 49.13 1.41 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.84 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 158.03 88.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 111.689 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -41.94 -19.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.074 3.183 . . . . 0.0 114.743 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.48 63.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.708 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.7 m -67.63 124.41 89.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.568 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 30.1 Cg_endo -70.64 174.91 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.05 1.833 . . . . 0.0 111.75 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.62 124.29 15.46 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.505 2.803 . . . . 0.0 113.838 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.86 9.35 86.41 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 115.492 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.646 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.9 m -85.84 -33.28 21.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.95 0.875 . . . . 0.0 110.379 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.8 p -153.83 151.37 29.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.325 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.61 85.0 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -126.49 82.06 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -92.75 131.66 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.204 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -156.8 157.87 35.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -161.46 60.71 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p 54.45 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.01 103.84 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.672 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 mm -120.6 133.8 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -103.01 -29.05 11.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.789 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.51 80.4 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.464 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -85.14 -48.71 8.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.74 131.87 78.8 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.2 Cg_exo -58.12 139.84 91.95 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.479 1.452 . . . . 0.0 110.654 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -47.24 -31.46 3.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.463 0.649 . . . . 0.0 111.29 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 9' ' ' PRO . 3.7 m -57.77 -26.69 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.108 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m -71.53 -23.84 61.84 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.066 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -35.62 75.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.43 -81.89 1.62 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.752 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.81 108.6 14.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.441 0.639 . . . . 0.0 112.107 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.75 51.64 1.94 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.801 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.84 159.53 83.69 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.234 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -52.77 -12.4 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.246 2.63 . . . . 0.0 114.799 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -24.6 63.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.257 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.82 124.1 87.72 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.823 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -55.63 171.1 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.199 2.6 . . . . 0.0 111.834 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.18 124.93 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.854 2.369 . . . . 0.0 111.551 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.88 15.3 81.75 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.367 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.2 m -85.5 -33.67 21.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.501 0.65 . . . . 0.0 109.846 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.128 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.96 81.25 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 89.09 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' VAL . 35.9 m -86.03 116.37 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.048 0.452 . . . . 0.0 111.115 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.77 142.26 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.106 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.87 24.89 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.285 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.926 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.73 139.64 53.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.61 88.05 2.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.976 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.3 mm -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.196 0.522 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -138.55 -24.78 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.293 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.05 77.12 1.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.166 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -85.59 -50.93 6.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.36 135.01 72.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 39.7 Cg_exo -59.72 137.1 74.88 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.131 1.22 . . . . 0.0 110.28 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -47.48 -32.49 5.23 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.769 0.795 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 2.3 m -57.93 -27.02 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.212 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.1 m -71.8 -21.88 61.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -69.43 -35.04 75.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.84 -88.54 1.84 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.147 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.11 107.93 15.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.2 t -82.68 59.64 4.84 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.83 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.48 160.81 80.08 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.76 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -41.89 -23.32 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.643 2.896 . . . . 0.0 114.51 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -19.96 62.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.105 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 22.7 m -68.03 124.36 89.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 16.7 Cg_exo -58.84 165.19 8.65 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.702 2.268 . . . . 0.0 111.688 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.0 129.83 22.89 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.031 2.488 . . . . 0.0 111.846 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 15.76 80.69 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -85.95 -52.82 5.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.544 0.672 . . . . 0.0 110.828 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.9 152.75 22.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.036 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.85 -56.08 9.97 Favored Glycine 0 C--N 1.319 -0.364 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.936 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 3.2 pm0 -57.35 100.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 28' ' ' VAL . 29.3 m -85.14 115.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.38 132.36 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.794 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.87 39.71 3.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -142.73 158.57 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.717 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -133.88 122.8 23.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 HD12 ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -154.73 153.42 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.332 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -115.95 -18.25 10.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.561 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.84 49.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 m -81.94 -47.47 12.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.982 0.42 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 4' ' ' ILE . 27.6 m -74.83 131.76 78.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.418 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 11' ' ' VAL . 41.5 Cg_exo -55.92 140.1 85.27 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.368 1.378 . . . . 0.0 110.423 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 -33.3 6.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.623 0.725 . . . . 0.0 111.105 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 4.3 m -58.32 -27.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.377 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.68 -23.95 61.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.255 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -35.43 75.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.9 -82.58 1.66 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.596 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' VAL . 3.7 m-20 -80.9 110.21 16.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.488 0.661 . . . . 0.0 112.423 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -82.56 49.59 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.751 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.549 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.23 157.55 89.65 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.539 -179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -42.58 -17.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.964 3.11 . . . . 0.0 114.724 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -27.76 65.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.793 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.51 124.53 89.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.6 Cg_endo -70.79 175.12 9.39 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.107 1.871 . . . . 0.0 111.952 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.42 121.99 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.527 2.818 . . . . 0.0 113.976 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.06 10.14 83.21 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.503 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.4 m -85.76 -34.75 21.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.98 0.89 . . . . 0.0 110.337 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.05 151.41 29.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.187 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.68 81.2 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.97 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -106.25 81.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.117 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.46 127.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.98 87.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.89 50.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.61 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 95.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.16 127.3 56.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -155.96 151.31 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 110.933 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -64.29 131.87 48.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.72 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.08 1.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.292 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -85.42 -52.14 6.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.901 0.381 . . . . 0.0 110.691 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 m -75.26 133.21 75.12 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.311 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HB2' ' CG2' ' A' ' 11' ' ' VAL . 34.4 Cg_exo -58.63 136.38 73.64 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.333 1.355 . . . . 0.0 110.535 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t -47.87 -31.56 5.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.778 0.799 . . . . 0.0 110.979 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' PRO . 2.4 m -57.85 -27.53 30.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 52.3 m -71.83 -21.23 61.71 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.296 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -35.92 76.1 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.44 -88.23 1.81 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.258 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.25 107.67 15.11 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -82.77 60.72 5.46 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.56 160.69 80.68 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.671 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -42.37 -22.41 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.737 2.958 . . . . 0.0 114.536 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -20.73 62.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.064 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 29.8 m -67.69 124.17 88.67 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.2 Cg_exo -59.01 167.36 5.71 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.974 2.449 . . . . 0.0 111.69 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.13 127.29 16.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.019 2.48 . . . . 0.0 112.132 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.13 80.78 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 m -85.85 -51.98 6.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.56 0.68 . . . . 0.0 110.801 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 p -85.73 152.78 22.79 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.057 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.53 83.54 0.18 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.219 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.47 94.61 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.08 134.09 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -139.21 114.68 9.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.88 27.33 7.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.88 0.372 . . . . 0.0 110.834 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.838 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -66.05 85.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -103.6 128.38 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.684 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -49.59 146.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.0 111.662 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.4 m -110.54 -25.37 10.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.937 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.25 90.58 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.458 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -86.13 -58.47 2.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.0 110.242 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 m -75.55 124.43 88.91 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.785 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 11' ' ' VAL . 31.8 Cg_exo -57.24 140.4 92.8 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.423 1.415 . . . . 0.0 109.581 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -47.37 -32.92 5.33 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.627 0.727 . . . . 0.0 111.129 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 5.8 m -58.42 -26.74 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 m -71.61 -23.45 61.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.18 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -35.58 75.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.85 -82.5 1.65 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.678 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.86 110.84 16.76 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 t -82.79 47.87 1.26 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.761 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -69.79 157.42 89.69 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.37 0.605 . . . . 0.0 111.719 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -41.67 -19.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.09 3.193 . . . . 0.0 114.655 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -25.17 63.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.808 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -67.17 124.57 89.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.532 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 36.5 Cg_endo -70.1 174.63 9.52 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.159 1.906 . . . . 0.0 111.9 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.23 123.98 14.26 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.541 2.827 . . . . 0.0 113.93 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.54 8.18 86.5 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.604 -1.18 . . . . 0.0 115.637 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 21.4 m -85.83 -34.21 21.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.013 0.906 . . . . 0.0 109.946 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.5 p -153.99 151.4 29.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.377 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.22 98.29 0.11 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.327 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -98.92 84.87 3.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.49 137.3 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 62.0 85.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.548 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 2.3 pp -94.76 28.21 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.344 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.944 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t 60.77 156.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.832 0.349 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.77 143.21 39.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.699 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.8 pp -154.3 147.33 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.76 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -125.42 -28.41 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 0.0 111.386 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.45 -82.57 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -161.86 -69.43 0.06 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.4 m -75.16 124.61 89.41 Favored Pre-proline 0 CA--C 1.512 -0.491 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.26 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB2' HG22 ' A' ' 11' ' ' VAL . 35.4 Cg_exo -58.31 140.54 94.79 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.495 1.463 . . . . 0.0 109.681 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -46.77 -32.52 3.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.47 0.652 . . . . 0.0 111.464 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 9' ' ' PRO . 4.3 m -58.18 -27.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.445 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.4 m -71.75 -22.99 61.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.143 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -35.16 74.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.48 -82.83 1.68 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.456 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.93 110.93 16.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.433 0.635 . . . . 0.0 112.646 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 t -82.62 48.95 1.38 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.837 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.536 ' OH ' ' HB ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -70.11 157.43 89.86 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.651 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.99 -18.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.02 3.147 . . . . 0.0 114.569 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -25.27 63.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.699 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.75 124.5 89.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.674 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 37.4 Cg_endo -71.33 174.15 11.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.268 1.978 . . . . 0.0 111.66 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.46 124.95 17.32 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.525 2.817 . . . . 0.0 113.688 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.87 8.61 86.49 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 114.758 -1.11 . . . . 0.0 115.477 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.613 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 20.6 m -85.94 -35.74 20.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.089 0.944 . . . . 0.0 110.489 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.6 p -153.93 151.37 29.35 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.049 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.41 95.36 0.1 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.816 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -129.14 61.03 1.54 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 110.868 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.59 117.26 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 54.74 87.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -107.61 50.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.624 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.831 -179.97 . . . . . . . . 0 0 . 1 stop_ save_